Selatinib is a reversible and orally active dual EGFR and ErbB2 inhibitor with IC50s of 13 nM and 22.5 nM, respectively. Selatinib has anticancer effects[1].
Molecular Weight:
565.06
Purity:
99.83
CAS Number:
[1275595-86-2]
Formula:
C29H26ClFN4O3S
Target:
EGFR
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted